Immune-mediated attack in relapsed Hodgkin's lymphoma

Lancet

Volumn 365, Issue 9475, 2005, Pages 1906-1908

  Corradini, Paolo ^a   Farina, Lucia ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB;

ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOTRANSPLANTATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; DISEASE COURSE; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; IMMUNE RESPONSE; NOTE; PRIORITY JOURNAL; RELAPSE; TREATMENT INDICATION;

EID: 20444413832     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66636-6     Document Type: Note

References (11)

1. JE Anderson, MR Litzow, FR Appelbaum Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience J Clin Oncol 11 1993 2342 50
2. G Akpek, RF Ambinder, S Piantadosi Long-term results of blood and marrow transplantation for Hodgkin's lymphoma J Clin Oncol 19 2001 4314 21
3. DL Porter, JM Connors, VM Van Deerlin Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies J Clin Oncol 17 1999 1234 43
4. N Milpied, AK Fielding, RM Pearce Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation J Clin Oncol 14 1996 1291 96
5. JL Gajewski, GL Phillips, KA Sobocinski Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease J Clin Oncol 14 1996 572 78
6. P Anderlini, SA Acholonu, GJ Okoroji Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response Bone Marrow Transplant 34 2004 511 14
7. P Dreger, L Uharek, B Glass Adoptive immunotherapy for treatment of Hodgkin's disease: proof of principle Bone Marrow Transplant 25 2000 S173
8. P Corradini, A Dodero, M Bregni Reduced-intensity conditioning followed by allogeneic transplantation in relapsed lymphomas: evidence for graft-versus-lymphoma effect in low grade and high grade histologies, but not in Hodgkin disease Blood 104 2004 230a
9. SP Robinson, G Taghipour, A Sureda Reduced intensity allogeneic stem cell transplantation for Hodgkin's disease: outcome depends primarily on disease status at the time of transplantation Blood 104 2004 639a
10. NA Marshall, LE Christie, LR Munro Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma Blood 103 2004 1755 62
11. J Delabie, WC Chan, DD Weisenburger, C De Wolf-Peeters The antigen-presenting cell function of Reed-Sternberg cells Leuk Lymph 18 1995 35 40